Literature DB >> 8059020

Lysosomal iron accumulation in diabetic nephropathy.

B J Nankivell1, Y C Tay, R A Boadle, D C Harris.   

Abstract

Iron accumulates within proximal tubular lysosomes in several models of renal disease and may play a role in the progression of proteinuric chronic renal disease by the generation of reactive oxygen species. In this study, tubular iron was examined at an ultrastructural level by energy dispersive x-ray spectrometry in streptozotocin (STZ) and BB diabetic rats, and in humans with diabetic nephropathy, and compared to their respective nondiabetic controls. Substantial amounts of iron accumulated in the secondary lysosomes of proximal tubules in STZ diabetic rats (4.16 +/- 0.47 iron-containing lysosomes/microns 2 x 10(-3) tubular area vs. 0.90 +/- 0.29 in controls, p < 0.001). Proximal tubular iron was related independently with urinary protein and transferrin excretion, suggesting increased cellular uptake of iron from the tubular fluid. Lysosomal iron accumulation was also associated with tubular damage (r = 0.55, p < 0.001). Minimal amounts of tubular iron were observed in BB diabetic and nondiabetic littermates. In humans with diabetic nephropathy, increased proximal tubular lysosomal iron concentration (35.6 +/- 13.0 mg% Fe vs. 9.5 +/- 2.7, p < 0.05) and numbers of iron-containing lysosomes were observed compared to nondiabetic controls, and the latter correlated with elevation of serum creatinine (r = 0.94, p = 0.016). These results suggest that filtered iron enters proximal tubular lysosomes across the brush-border membrane and are consistent with a role for iron in causing the tubular damage of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8059020     DOI: 10.3109/08860229409044877

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  13 in total

1.  Chelation of dietary iron prevents iron accumulation and macrophage infiltration in the type I diabetic kidney.

Authors:  Tatsuyori Morita; Daisuke Nakano; Kento Kitada; Satoshi Morimoto; Atsuhiro Ichihara; Hirofumi Hitomi; Hiroyuki Kobori; Ichiro Shiojima; Akira Nishiyama
Journal:  Eur J Pharmacol       Date:  2015-03-26       Impact factor: 4.432

2.  Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis.

Authors:  Amélie Dendooven; Olivia van Oostrom; Dionne M van der Giezen; Jan Willem Leeuwis; Cristel Snijckers; Jaap A Joles; Elizabeth J Robertson; Marianne C Verhaar; Tri Q Nguyen; Roel Goldschmeding
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

3.  Dysregulation of the sensory and regulatory pathways controlling cellular iron metabolism in unilateral obstructive nephropathy.

Authors:  James A Votava; Shannon R Reese; Kathryn M Deck; Christopher P Nizzi; Sheila A Anderson; Arjang Djamali; Richard S Eisenstein
Journal:  Am J Physiol Renal Physiol       Date:  2021-11-29

4.  Poor lysosomal membrane integrity in proximal tubule cells of haptoglobin 2-2 genotype mice with diabetes mellitus.

Authors:  Rabea Asleh; Farid M Nakhoul; Rachel Miller-Lotan; Hoda Awad; Dan Farbstein; Nina S Levy; Nakhoul Nakhoul; Theodore C Iancu; Irena Manov; Michael Laue; Maret G Traber; Katie M Lebold; Andrew P Levy
Journal:  Free Radic Biol Med       Date:  2012-06-27       Impact factor: 7.376

5.  The HFE gene is associated to an earlier age of onset and to the presence of diabetic nephropathy in diabetes mellitus type 2.

Authors:  Rafael Oliva; Anna Novials; Mayka Sánchez; Marga Villa; Mercedes Ingelmo; Mónica Recasens; Carlos Ascaso; Miquel Bruguera; Ramón Gomis
Journal:  Endocrine       Date:  2004-07       Impact factor: 3.633

6.  A hemochromatosis-causing mutation C282Y is a risk factor for proliferative diabetic retinopathy in Caucasians with type 2 diabetes.

Authors:  Borut Peterlin; Mojca Globočnik Petrovič; Jana Makuc; Marko Hawlina; Daniel Petrovič
Journal:  J Hum Genet       Date:  2003-11-15       Impact factor: 3.172

Review 7.  The Cross-Link between Ferroptosis and Kidney Diseases.

Authors:  Jingyu Wang; Yi Liu; Yaqing Wang; Li Sun
Journal:  Oxid Med Cell Longev       Date:  2021-05-03       Impact factor: 6.543

Review 8.  Homocysteine, iron and cardiovascular disease: a hypothesis.

Authors:  Joseph E Baggott; Tsunenobu Tamura
Journal:  Nutrients       Date:  2015-02-06       Impact factor: 5.717

9.  Tubular iron deposition and iron handling proteins in human healthy kidney and chronic kidney disease.

Authors:  Sanne van Raaij; Rachel van Swelm; Karlijn Bouman; Maaike Cliteur; Marius C van den Heuvel; Jeanne Pertijs; Dominic Patel; Paul Bass; Harry van Goor; Robert Unwin; Surjit Kaila Srai; Dorine Swinkels
Journal:  Sci Rep       Date:  2018-06-19       Impact factor: 4.379

10.  Prevalence, characteristics, and prognostic significance of HFE gene mutations in type 2 diabetes: the Fremantle Diabetes Study.

Authors:  Timothy M E Davis; John Beilby; Wendy A Davis; John K Olynyk; Gary P Jeffrey; Enrico Rossi; Conchita Boyder; David G Bruce
Journal:  Diabetes Care       Date:  2008-06-19       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.